LEVONORGESTREL AND ETHINYL ESTRADIOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levonorgestrel And Ethinyl Estradiol, and what generic alternatives are available?
Levonorgestrel And Ethinyl Estradiol is a drug marketed by Amneal Pharms, Glenmark Pharms Ltd, Lupin Ltd, Watson Labs, Xiromed, Barr, Dr Reddys Labs Sa, Hetero Labs, and Naari Pte Ltd. and is included in twenty-nine NDAs.
The generic ingredient in LEVONORGESTREL AND ETHINYL ESTRADIOL is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVONORGESTREL AND ETHINYL ESTRADIOL?
- What are the global sales for LEVONORGESTREL AND ETHINYL ESTRADIOL?
- What is Average Wholesale Price for LEVONORGESTREL AND ETHINYL ESTRADIOL?
Summary for LEVONORGESTREL AND ETHINYL ESTRADIOL
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 29 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 60 |
What excipients (inactive ingredients) are in LEVONORGESTREL AND ETHINYL ESTRADIOL? | LEVONORGESTREL AND ETHINYL ESTRADIOL excipients list |
DailyMed Link: | LEVONORGESTREL AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for LEVONORGESTREL AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alexion Pharmaceuticals, Inc. | Phase 1 |
FHI 360 | N/A |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A |
See all LEVONORGESTREL AND ETHINYL ESTRADIOL clinical trials
Pharmacology for LEVONORGESTREL AND ETHINYL ESTRADIOL
Drug Class | Estrogen Progestin Progestin-containing Intrauterine Device Progestin-containing Intrauterine System |
Mechanism of Action | Estrogen Receptor Agonists |
Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for LEVONORGESTREL AND ETHINYL ESTRADIOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xiromed | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 205131-001 | Dec 14, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Xiromed | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 200492-001 | May 27, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Amneal Pharms | LEVONORGESTREL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 203871-001 | Nov 13, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |